Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology.
Viola-Villegas NT, Rice SL, Carlin S, Wu X, Evans MJ, Sevak KK, Drobjnak M, Ragupathi G, Sawada R, Scholz WW, Livingston PO, Lewis JS.
Viola-Villegas NT, et al. Among authors: scholz ww.
J Nucl Med. 2013 Nov;54(11):1876-82. doi: 10.2967/jnumed.113.119867. Epub 2013 Sep 12.
J Nucl Med. 2013.
PMID: 24029655
Free PMC article.